Albany Molecular
Article Abstract:
The price appreciation potential of the shares of Albany Molecular Research Inc. for the years 2010-2012 is discussed. The Albany, New York-based company is a contract research organization specializing in applications for the pharmaceutical, biotechnology and life sciences industries.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Pharmaceutical preparations, Evaluation, Pharmaceutical industry, Stocks, Stock prices
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Albany Molecular Research
Article Abstract:
A comparative analysis of the company sales and earnings and the financial details of Albany Molecular Research from 1998 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
United States, Sales, profits & dividends, CHEMICALS AND ALLIED PRODUCTS, Company sales and earnings, Chemical industry, Company earnings/profit, Pesticides industry, Herbicides, Sulphur industry
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: United States, Securities, Company securities, Albany Molecular Research Inc., AMRI
Similar abstracts:
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.